{"article": [{"url": "https://www.marketwatch.com/story/vaxarts-stock-rallies-15-after-it-gets-clearance-to-begin-human-trials-of-covid-19-vaccine-candidate-2020-09-14", "published": 1600071500.0, "headline": "Vaxart's stock rallies 15% after it gets clearance to begin human trials of COVID-19 vaccine candidate", "body": "Shares of Vaxart Inc. VXRT, +0.97% jumped 15.6% in premarket trading on Monday after the company said it had received the go-ahead from the Food and Drug Administration to begin testing its experimental oral COVID-19 vaccine in a Phase 1 clinical trial. Vaxart said it expects to begin recruiting participants for the open-label study sometime this month. Shares of the preclinical company have soared 1,412.1% so far this year, while the S&P 500 SPX, +0.87% is up 3.4%."}]}